UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$564.94
-4.24 (-0.74%)
Performance
1D
—
1W
—
1M
—
3M
+19.41%
6M
+23.02%
1Y
+81.77%
YTD
+13.73%
Open$569.17
Previous Close$569.18
Day High$573.52
Day Low$561.20
52W High$609.35
52W Low$272.12
Volume—
Avg Volume415.8K
Market Cap24.24B
P/E Ratio18.16
EPS$27.90
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$485.49
Above
SMA 200
$394.55
Above
RSI (14)
60.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-84.3% upside
Current
$564.94
$564.94
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.85B | 2.42B | 2.73B |
| Net Income | 1.20B | 911.78M | 406.29M |
| Profit Margin | 41.9% | 39.8% | 14.9% |
| EBITDA | 1.47B | 1.18B | 733.08M |
| Free Cash Flow | — | — | 513.48M |
| Rev Growth | +18.0% | +18.0% | +4.0% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |